Perspectives of Postpartum Women on Intermittent Presumptive Treatment in Uganda: Implications for Malaria Prevention: a Qualitative Study

Overview

Journal Malar J

Publisher Biomed Central

Specialty Tropical Medicine

Date 2024 Nov 7

PMID 39506733

Authors

Fatuma Namusoke

Allan Lugaajju

William Buwembo

Mpungu Steven Kiwuuwa

Mark Kaddumukasa

Affiliations

Soon will be listed here.

Abstract

Background: Malaria during pregnancy leads to many deaths in Africa. COVID-19 contributed to more malaria cases due to interruptions in prevention efforts. Intermittent presumptive treatment (IPTP) is an effective malaria prevention strategy for pregnant women, but adoption barriers still exist. The study aim was to explore barriers to the adoption of IPTP at Kawempe National Referral Hospital (KNRH) Uganda.

Methods: In a qualitative study design, data was collected using focus group discussions. A total of 37 postpartum mothers were interviewed in six focus group discussions. The interviews were conducted using a structured guide to explore barriers to IPTP implementation at KNRH. The data was transcribed, coded, and analysed using NVivo 10.

Results: The study found that mothers lacked adequate knowledge about IPTP, faced socioeconomic and cultural constraints, fear of side effects, a high pill burden, and experience of health system challenges as major themes of barriers to optimal IPTP use.

Conclusions And Recommendations: Challenges in the service delivery and inadequate information in regard to importance and expected side effects were identified by the users as the major barriers to IPTP delivery in public health care setting. Improving delivery of focused health education talks and health work attitude and delivery chain for IPTP in the health facilities are recommended to increase its uptake.

References

Awantang G, Babalola S, Koenker H, Fox K, Toso M, Lewicky N . Malaria-related ideational factors and other correlates associated with intermittent preventive treatment among pregnant women in Madagascar. Malar J. 2018; 17(1):176. PMC: 5918989. DOI: 10.1186/s12936-018-2308-3. View

Aberese-Ako M, Magnussen P, Ampofo G, Gyapong M, Ansah E, Tagbor H . An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context. PLoS One. 2021; 16(10):e0257666. PMC: 8496863. DOI: 10.1371/journal.pone.0257666. View

Iuga A, McGuire M . Adherence and health care costs. Risk Manag Healthc Policy. 2014; 7:35-44. PMC: 3934668. DOI: 10.2147/RMHP.S19801. View

Mubiri P, Nambuya H, Kajjo D, Butrick E, Namazzi G, Santos N . Birthweight and gestational age-specific neonatal mortality rate in tertiary care facilities in Eastern Central Uganda. Health Sci Rep. 2020; 3(4):e196. PMC: 7592235. DOI: 10.1002/hsr2.196. View

Abdus-Salam R, Adeniyi A, Bello F . Antenatal Clinic Waiting Time, Patient Satisfaction, and Preference for Staggered Appointment-A Cross-Sectional Study. J Patient Exp. 2021; 8:23743735211060802. PMC: 8640308. DOI: 10.1177/23743735211060802. View

Walker P, Floyd J, Ter Kuile F, Cairns M . Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. PLoS Med. 2017; 14(2):e1002243. PMC: 5330448. DOI: 10.1371/journal.pmed.1002243. View

Kalu G, Francis J, Ibisomi L, Chirwa T, Kagura J . Factors associated with the uptake of Intermittent Preventive Treatment (IPTp-SP) for malaria in pregnancy: Further analysis of the 2018 Nigeria Demographic and Health Survey. PLOS Glob Public Health. 2023; 3(2):e0000771. PMC: 10021516. DOI: 10.1371/journal.pgph.0000771. View

Farrell B, Merkley V, Ingar N . Reducing pill burden and helping with medication awareness to improve adherence. Can Pharm J (Ott). 2013; 146(5):262-9. PMC: 3785195. DOI: 10.1177/1715163513500208. View

Martin M, Venantius K, Patricia N, Bernard K, Keith B, Allen K . Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda. Malar J. 2020; 19(1):153. PMC: 7161174. DOI: 10.1186/s12936-020-03230-8. View

10.

Jana A, Saha U, Reshmi R, Muhammad T . Relationship between low birth weight and infant mortality: evidence from National Family Health Survey 2019-21, India. Arch Public Health. 2023; 81(1):28. PMC: 9942291. DOI: 10.1186/s13690-023-01037-y. View

11.

Ayele A, Tenaw L, Kassa B, Mihretie G, Belay H, Teffera A . Knowledge and practice of essential newborn care and associated factors among women in Ethiopia: systematic review and meta-analysis. Reprod Health. 2022; 19(1):172. PMC: 9351089. DOI: 10.1186/s12978-022-01480-0. View

12.

Ameyaw E . Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey. Malar J. 2022; 21(1):285. PMC: 9547429. DOI: 10.1186/s12936-022-04299-z. View

13.

Sheppard V, Zambrana R, OMalley A . Providing health care to low-income women: a matter of trust. Fam Pract. 2004; 21(5):484-91. DOI: 10.1093/fampra/cmh503. View

14.

Nekaka R, Nteziyaremye J, Oboth P, Iramiot J, Wandabwa J . Malaria preventive practices and delivery outcomes: A cross-sectional study of parturient women in a tertiary hospital in Eastern Uganda. PLoS One. 2020; 15(8):e0237407. PMC: 7413511. DOI: 10.1371/journal.pone.0237407. View

15.

Okedo-Alex I, Akamike I, Ezeanosike O, Uneke C . Determinants of antenatal care utilisation in sub-Saharan Africa: a systematic review. BMJ Open. 2019; 9(10):e031890. PMC: 6797296. DOI: 10.1136/bmjopen-2019-031890. View

16.

Okethwangu D, Opigo J, Atugonza S, Kizza C, Nabatanzi M, Biribawa C . Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016. Malar J. 2019; 18(1):250. PMC: 6660695. DOI: 10.1186/s12936-019-2883-y. View

17.

Ogba P, Badru O, Ibhawoh B, Archer N, Baumann A . Perceptions of sulphadoxine-pyrimethamine use among pregnant women in sub-Saharan Africa: a scoping review. Malariaworld J. 2023; 14:1. PMC: 10117231. DOI: 10.5281/zenodo.7828460. View

18.

Solanke B, Yinusa R, Oyeleye O, Oluwatope O, Ilesanmi B, Oni T . Using Andersen's behavioral model of health care use for intermittent preventive treatment of malaria in pregnancy in Nigeria. BMC Pregnancy Childbirth. 2023; 23(1):315. PMC: 10158312. DOI: 10.1186/s12884-023-05648-9. View

19.

Tusting L, Rek J, Arinaitwe E, Staedke S, Kamya M, Cano J . Why is malaria associated with poverty? Findings from a cohort study in rural Uganda. Infect Dis Poverty. 2016; 5(1):78. PMC: 4972958. DOI: 10.1186/s40249-016-0164-3. View

20.

Peters G, Naidoo M . Factors influencing the use of intermittent preventive treatment of pregnant women seeking care at primary healthcare facilities in the Bwari Area Council, Abuja, Nigeria. Afr J Prim Health Care Fam Med. 2020; 12(1):e1-e8. PMC: 7203208. DOI: 10.4102/phcfm.v12i1.2256. View